Error-free chromosome segregation depends on the precise regulation of phosphorylation to stabilize kinetochore-microtubule attachments (K-fibres) on sister chromatids that have attached to opposite spindle poles (bi-oriented) 1 . In many instances, phosphorylation correlates with K-fibre destabilization 2-7 . Consistent with this, multiple kinases, including Aurora B and Plk1, are enriched at kinetochores of mal-oriented chromosomes when compared with bi-oriented chromosomes, which have stable attachments 2,8 . Paradoxically, however, these kinases also target to prometaphase chromosomes that have not yet established spindle attachments and it is therefore unclear how kinetochore-microtubule interactions can be stabilized when kinase levels are high. Here we show that the generation of stable K-fibres depends on the B56-PP2A phosphatase, which is enriched at centromeres/kinetochores of unattached chromosomes. When B56-PP2A is depleted, K-fibres are destabilized and chromosomes fail to align at the spindle equator. Strikingly, B56-PP2A depletion increases the level of phosphorylation of Aurora B and Plk1 kinetochore substrates as well as Plk1 recruitment to kinetochores. Consistent with increased substrate phosphorylation, we find that chemical inhibition of Aurora or Plk1 restores K-fibres in B56-PP2A-depleted cells. Our findings reveal that PP2A, an essential tumour suppressor 9 , tunes the balance of phosphorylation to promote chromosome-spindle interactions during cell division.
most abundant eukaryotic serine/threonine phosphatases, target to kinetochores (PP1; ref. 11) or centromeres (PP2A; refs [12] [13] [14] during mitosis. PP1, however, localizes to kinetochores only after chromosomes have bi-oriented and preventing PP1 targeting to the kinetochore does not impair chromosome alignment 15, 16 , indicating that it may not be essential for the establishment of kinetochore-microtubule interactions in prometaphase. Therefore, we examined whether PP2A plays a role in this process.
We reasoned that a high-resolution live-cell localization analysis may provide information on PP2A functions at centromeres. PP2A holoenzymes are composed of a common catalytic and scaffold subunit, and a variable regulatory subunit 17 ( Fig. 1a) . To analyse the dynamics of PP2A localization during mitosis we fused the core subunits to green fluorescent protein (GFP). As expected, this approach was unsuccessful for the catalytic subunit, an abundant protein that cannot be overexpressed 18 . Therefore, we examined the localization dynamics of GFP-scaffold stably expressed in human RPE1 cells. Near-simultaneous differential interference contrast (DIC) and real-time confocal microscopy of mitotic cells revealed that the scaffold was enriched at centrosomes (Fig. 1b, arrows) and to discrete regions on chromosomes (Fig. 1b, arrowheads) , which corresponded to centromere/kinetochore targeting (Fig. 1c,d ). Unexpectedly, scaffold centromere/kinetochore targeting decreased between prometaphase and metaphase in RPE1 (Fig. 1b) and HeLa cells ( Supplementary  Fig. S1a ). GFP-scaffold signal was enriched on centromeres of chromosomes that had not congressed to the metaphase plate (Fig. 1c,d , compare centromere 1 and 2), indicating that its targeting may be sensitive to chromosome-microtubule attachment status. To investigate this, we arrested cells at metaphase and tracked the distribution of GFP-scaffold before and after depolymerization of microtubules by nocodazole. Strikingly, within minutes of nocodazole addition, GFP-scaffold became enriched on centromeres (Fig. 1e) , confirming attachment-sensitive localization.
To identify regulatory subunits that also reveal a microtubuleattachment-dependent localization, we carried out a comprehensive localization analysis for all regulatory subunit genes, using stable cell lines expressing GFP fusions of individual subunits. In humans, there are at least fifteen regulatory subunits, distributed over four evolutionarily conserved families 17 but the localization dynamics of only two subunits have been reported thus far 19 . By live-cell imaging, only the five members of the B56 (B ) family of regulatory subunits were observed at centromeres ( Fig. 2a and Supplementary Fig. S1b-e) . Similarly to the scaffold, the level of B56 targeting was highest in prometaphase, and was decreased (B56α, ε) or undetectable (B56β, γ, δ) by metaphase (Fig. 2a) . Furthermore, when we repeated the nocodazole wash-in assay, GFP-B56α, β, δ and ε targeting to centromeres increased within minutes (Fig. 2b) , confirming microtubule-attachment-sensitive targeting. We did not consistently detect targeting of B56γ to centromeres in this assay (data not shown). Microtubule-sensitive localization of endogenous B56α to centromeres/kinetochores was confirmed by immunofluorescence microscopy in unperturbed cells ( Supplementary  Fig. S2 ), and in a nocodazole wash-in assay (Fig. 2c) . Together, these data indicate that B56-PP2A targeting to centromeres/kinetochores is sensitive to kinetochore-microtubule attachment status.
L E T T E R S
Microtubule-attachment-sensitive kinetochore targeting is a hallmark of proteins that regulate microtubule binding (for example, dynein and Cenp-E; ref. 20) and/or mitotic checkpoint signalling (for example, Mad2; ref. 21 ). However, we considered a requirement for B56-PP2A in the spindle checkpoint unlikely because depletion of the scaffold results in a mitotic arrest in human cells 12, 14 . In mammals, one challenge in assigning PP2A functions during the cell cycle is the potential for redundancy in regulatory subunit function. Thus, although PP2A is essential for mitosis 12, 14 , knockdown of individual regulatory subunits in human cells has not been observed to perturb chromosome segregation 22 . Redundancy may be particularly relevant to the B56 family, which share a pseudo HEAT repeat structure with ∼80% sequence identity 23, 24 . Furthermore, depletion of the scaffold or chemical inhibition of the catalytic subunit cannot provide information on specific regulatory subunits. Therefore, we chose to deplete B56α-ε proteins using RNAi. We used two non-overlapping pools of siRNA (labelled hereafter as B56-PP2A-siRNA pools), with each pool composed of siRNA oligonucleotides targeting each B56 gene (see Methods), and analysed the extent of depletion by two methods. First, by western blot analysis, each pool partially decreased protein levels of endogenous B56α, β and δ ( Supplementary Fig. S3a ). We confirmed that GFP fusions of B56γ and ε were depleted, as we were unable to detect the endogenous proteins using available antibodies ( Supplementary Fig. S3b ). Second, we confirmed that B56-PP2A-siRNA cells had decreased levels of GFP-scaffold at centromeres/kinetochores (Fig. 3a) . As expected 12, 14 , nocodazole-treated B56-PP2A-siRNA cells accumulated in mitosis ( Supplementary Fig. S4a ), indicating an intact spindle checkpoint.
To examine whether B56-PP2A-siRNA treatment impairs chromosome-microtubule attachment, we made use of the fact that K-fibres are preferentially stable during a brief incubation at 4
• C, whereas other spindle microtubules depolymerize 25 . First, we scored the presence of K-fibres in any mitotic cell that had not yet entered anaphase. B56-PP2A siRNA increased the fraction of mitotic cells that contained few or no K-fibres (Fig. 3b) , indicating that B56-PP2A is required for proper chromosome-spindle interactions. Second, we used transient nocodazole arrest to accumulate mitotic cells lacking microtubule attachments and then released cells into media containing proteasome inhibitor for 40 min, sufficient time for control cells to generate K-fibres (Fig. 3c) . In contrast, B56-PP2A-siRNA cells typically had numerous kinetochores lacking K-fibres (Fig. 3c ) and most contained few or no K-fibres (Fig. 3d) . To confirm the specificity of our phenotype, we generated stable cell lines overexpressing siRNA-resistant B56α or B56β ( Supplementary Fig. S3c ). When these cell lines were transfected with B56-PP2A siRNA, K-fibres persisted (Fig. 3d) .
To examine whether B56-PP2A siRNA impairs alignment of chromosomes at the spindle equator, we analysed chromosome alignment in metaphase-arrested cells. Consistent with defects in chromosome-spindle attachments, individual B56-PP2A-siRNA cells had numerous misaligned chromosomes (Fig. 3e) . Overall, B56-PP2A siRNA resulted in an eightfold increase in the fraction of cells with misaligned chromosomes, and overexpression of an siRNA-resistant B56 regulatory subunit rescued this defect (Fig. 3f) . We conclude that B56-PP2A is required to establish stable kinetochore-microtubule attachments and align chromosomes at the spindle equator.
Recent reports indicate that PP2A plays an important role in regulating sister-chromatid cohesion [12] [13] [14] . B56 regulatory subunits have been linked to this function through their association with Sgo1 (refs 12-14) , a centromeric protein that maintains cohesion and regulates K-fibre stability [26] [27] [28] . To examine whether cohesion is lost in our experiments, we isolated chromosomes from B56-PP2A-siRNA cells and found that at least 97% of chromatids had paired kinetochores (Fig. 3g) , indicating that centromeric cohesion is preserved. We also measured inter-kinetochore distances in metaphase-arrested cells, which are expected to increase if cohesion at the centromere is compromised. We found, however, that inter-kinetochore distances in B56-PP2A-siRNA cells were equal to or less than in control cells, consistent with intact cohesion (Supplementary Fig. S5 ). Finally, we confirmed that centromere targeting of Sgo1 is preserved in B56-PP2A-siRNA cells ( Fig. 3h and Supplementary Fig. S4b,c) . Together, these data indicate that perturbations in centromeric cohesion and/or Sgo1 targeting cannot account for the defects in kinetochore-microtubule attachment observed in B56-PP2A-siRNA cells.
Defects in K-fibre stability in B56-PP2A-siRNA cells could be due to an imbalance in substrate phosphorylation and/or failure to recruit proteins that bind kinetochores to microtubules. To investigate the latter possibility, we examined the kinetochore targeting of three proteins in the KMN network (Dsn1, Knl1 and Hec1), the core microtubule binding complex at the kinetochore 29 . It has been shown that Dsn1 and Hec1 levels at kinetochores are not sensitive to microtubule binding, whereas Knl1 recruitment increases 27% in nocodazole-arrested cells when compared with metaphase cells 6 . Therefore, to exclude effects of microtubule sensitivity, we included nocodazole in our analyses. Under these conditions, Dsn1 and Hec1 levels were unchanged by B56-PP2A-siRNA treatment, and Knl1 levels were modestly increased (1.4-fold), indicating that overall KMN network targeting is preserved in B56-PP2A-siRNA cells (Fig. 4a ).
To determine whether the level of phosphorylation at kinetochores is increased in B56-PP2A-siRNA cells, we analysed substrates of Aurora B, a key regulator of microtubule attachment stability 30 . We chose two KMN network substrates (Ser 100 on Dsn1 and Ser 24 on Knl1), whose phosphorylation decreases microtubule binding affinity 6 . In prometaphase cells, the level of phosphorylation of both substrates was increased in B56-PP2A-siRNA cells when compared with controls (Fig. 4b) . However, because modification of these substrates is sensitive to microtubule attachment status, as is Knl1 recruitment 6 (and because B56-PP2A siRNA destabilizes K-fibres), it was necessary to compare phosphorylation levels on kinetochores with similar inter-kinetochore spacing, a read-out for microtubule attachments. This analysis revealed that on kinetochores under comparable microtubule-dependent pulling forces (defined as a 1.2-1.5 µm inter-kinetochore stretch), B56-PP2A siRNA increased the mean level of phosphorylation of Dsn1 and Knl1 by 1.8-and 2.3-fold, respectively (Fig. 4b) . After accounting for changes in Knl1 targeting (Fig. 4a) , the net increase in phospho-Knl1 is 1.6-fold. Together, these analyses indicate that B56-PP2A limits the level of phosphorylation of these Aurora B substrates. In nocodazole, B56-PP2A siRNA did not increase the level of Dsn1 phosphorylation and the slight increase in the level of Knl1 phosphorylation could be attributed to higher levels of Knl1 at the kinetochore (Fig. 4c) . It is noteworthy that the level of phosphorylation of Dsn1 and Knl1 at these sites increases 7-and 2-fold respectively in nocodazole-treated when compared with prometaphase cells 6 . Thus, the level of phosphorylation at these sites may approach 100% in nocodazole, in which case loss of B56-PP2A would not further increase the level of phosphorylation.
To determine whether suppressing Aurora B can rescue the B56-PP2A-siRNA phenotype, cells were arrested in mitosis, followed by wash-in of chemical inhibitors of Aurora 31, 32 (hesperadin or ZM447439) or control solvent. As expected, control cells had coldstable K-fibres, whereas many B56-PP2A-siRNA cells did not (Fig. 4d) . Strikingly, Aurora inhibition was sufficient to restore K-fibres in B56-PP2A-siRNA-treated cells (Fig. 4d) and both inhibitors restored K-fibres to nearly all kinetochores (Fig. 4e) . Together, these data indicate that the defects in kinetochore-microtubule interactions in B56-PP2A-siRNA cells are due, at least in part, to increased levels of phosphorylation of Aurora B substrates.
To examine whether B56-PP2A attenuates the signalling of kinetochore kinases other than Aurora B, we examined Plk1. Remarkably, wash-in of the Plk1 inhibitor BI2536 (ref. 33 ) also restored K-fibres in B56-PP2A-siRNA cells (Fig. 5a,b) . Consistent with this, the level of phosphorylation of a Plk1 kinetochore substrate, Ser 676 on BubR1 (ref. 34) , was increased in prometaphase cells following B56-PP2A-siRNA treatment (Fig. 5c) . Furthermore, even in the absence of attachments, B56-PP2A-siRNA treatment resulted in a threefold increase in the level of phospho-BubR1 staining, without affecting BubR1 protein levels at kinetochores (Fig. 5d) , indicating that B56-PP2A modulates the phosphorylation level of a Plk1 substrate in addition to Aurora B substrates. BubR1 phosphorylation was undetectable in a cell line stably overexpressing siRNA-resistant B56β (Fig. 5d) , consistent with this site being a potential B56-PP2A substrate. Taken together, these analyses reveal that a decrease in the level of PP2A at the centromere increases the level of phosphorylation of multiple kinetochore proteins. Considering that Plk1 targeting depends on docking to phospho-epitopes 35 , we reasoned that B56-PP2A-siRNA treatment might increase Plk1 recruitment to kinetochores. Consistent with this, B56-PP2A siRNA increased Plk1 kinetochore targeting in prometaphase cells (Fig. 5c) . However, because Plk1 recruitment to kinetochores is sensitive to microtubule attachment status 2 , we examined Plk1 targeting in nocodazole-treated cells. Strikingly, B56-PP2A-siRNA treatment resulted in a 2.5-fold increase in Plk1 kinetochore targeting (Fig. 5d) . This result was confirmed with a second pool of B56-PP2A siRNA (data not shown). Critically, overexpression of siRNA-resistant B56β rescued this defect (Fig. 5d) . We conclude that, in addition to regulating the phosphorylation of kinase substrates, B56-PP2A also controls targeting of Plk1.
At the start of mitosis, all chromosomes are unattached to the spindle. Cytological studies indicate that initial kinetochore-microtubule interactions during prometaphase consist of one or a few microtubules, with microtubule occupancy increasing to ∼25 microtubules per kinetochore on aligned chromosomes by metaphase 36, 37 . Several kinases, including Aurora B and Plk1 (refs 2,8) , are enriched at unattached kinetochores, which may indicate high levels of substrate phosphorylation. For Aurora B, a vast body of data involving phospho-mimetic substrates, kinase mis-targeting and kinase inhibition indicates that high levels of substrate phosphorylation at the kinetochore would lead to unstable attachments, both by disrupting kinetochore-microtubule contacts and by increasing the turnover of kinetochore-bound microtubules 30 . This creates a paradox for how K-fibres form during prometaphase. It has also been shown that phosphorylation can 'fine-tune' the strength of kinetochore-microtubule interactions 6 , but contributions from PP2A, or any other phosphatase, during the capture of microtubules by kinetochores remained unclear.
Our data support a model in which B56-PP2A is an essential regulator of chromosome-spindle attachments. At the start of mitosis, B56-PP2A is enriched on unattached chromosomes (Fig. 5e, top) where it counteracts kinases, decreasing phosphorylation to levels that stabilize kinetochore-microtubule binding (Fig. 5e, middle) . Notably, even a modest decrease in the level of B56-PP2A alters the phosphorylation landscape at kinetochores, preventing the stabilization of K-fibres. As microtubules contact the kinetochore, B56-PP2A is removed, as are a subset of kinases (for example, Plk1; ref. 2) . Kinetochore accessibility of the remaining kinase, Aurora B, is decreased when chromosomes are bi-oriented and proper inter-and intra-kinetochore tension is established 8, 38 (Fig. 5e, bottom) . Interestingly, the redistribution of B56-PP2A from the centromere towards the kinetochore on chromatids that have come under tension (Fig. 5e, middle) may ensure timely dephosphorylation of Aurora B and Plk1 substrates on kinetochores that have bi-oriented. Although this function has been attributed to PP1 (refs 15,16) , recent work in yeast reveals the essential function of kinetochore PP1 is to silence the spindle checkpoint 39 . Misregulation of PP2A is considered a prerequisite for malignancy in human cells, but less is understood about which phospho-signalling networks are associated with tumorigenesis 9 . Interestingly, point mutations in the scaffold that disrupt binding to the B56 regulatory subunits have been identified in lung and breast carcinomas 40 . Our data indicate that these mutations may increase the frequency of whole chromosome gain or loss, the most common form of chromosomal instability in human tumours 41 , through disruption of kinetochore-microtubule interactions.
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METHODS
Cell culture, transfection and inhibitor treatments. Cells were grown at 37 • C in a humidified atmosphere with 5% CO 2 in DMEM (HeLa, 293-ampho) or 1:1 DMEM/F12 media (RPE1) from Invitrogen supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals), 1× penicillin-streptomcyin and non-essential amino acids (Invitrogen) and 2 mM l-glutamine (Invitrogen). Cells used for live-cell imaging or immunofluorescence microscopy were grown on no. 1.5 glass coverslips (Fisher Scientific) coated with poly-d-lysine (Sigma). 293-ampho cells were transfected according to a calcium phosphate protocol to generate retroviruses. Virus-containing medium was supplemented with 4 µg ml −1 Polybrene (Sigma) and applied to target cells, followed by selection with puromycin (Sigma). Nocodazole (Sigma), MG132 (Boston Biochem), ZM447439 (Tocris Bioscience), BI2536 (Selleck Biochemicals) and hesperadin (synthesized in the Kapoor laboratory) were dissolved in dimethylsulphoxide (DMSO). For siRNA treatments, 1.7 × 10 5 RPE1 cells were transfected with 150 pmol siRNA and 7.5 µl Lipofectamine RNAi Max (Invitrogen) following the manufacturer's reverse-transfection protocol and immediately plated onto no 1.5 glass coverslips. In all experiments, cells were fixed or lysed at 42-46 h post-transfection (Fisher Scientific). An siRNA targeting mCherry (5 -GCUCCAAGGCCUACGUGAAUU-3 ) was used for control transfections.
To generate B56 family siRNA pools, two individual siRNAs from Dharmacon smart pools for each B56 gene determined to be effective in decreasing protein levels of endogenous and/or GFP-tagged B56 genes were chosen. siRNAs were mixed at equimolar ratios, with the exception of B56ε siRNA, which was included at 1.5-fold relative to the other siRNAs. siRNAs used in the B56 family pools are: B56α(PPP2R5A), 5 -GCUCAAAGAUGCCACUUCA-3 (pool 1) and 5 -UGAAUGAACUGGUUGAGUA-3 (pool 2); B56β(PPP2R5B), 5 -CGCAUGAUCUCAGUGAAUA-3 (pool 1) and 5 -GAACAAUGAGUAUAUC-CUA-3 (pool 2); B56γ (PPP2R5G), 5 -GGAUUUGCCUUACCACUAA-3 (pool 1) and 5 -GGAAGAUGAACCAACGUUA-3 (pool 2); B56δ(PPP2R5G), 5 -UC-CAUGGACUGAUCUAUAA-3 (pool 1) and 5 -UGACUGAGCCGGUAAUUGU-3 (pool 2); B56ε(PPP2R5E), 5 -UUAAUGAACUGGUGGACUA-3 (pool 1) and 5 -GCACAGCUGGCAUAUUGUA-3 (pool 2).
Plasmid construction. Open reading frames for PP2A subunits were purchased from OpenBiosystems and cloned into pDONR201 using Gateway technology (Invitrogen) and sequenced before recombination into GFP-tagged retroviral vectors. Amino-and carboxy-terminal GFP fusion retroviral destination vectors were cloned from a parent vector, pMSCVpuro (Clontech), compatible with Gateway cloning (a gift from W. Harper, Harvard Medical School, USA). A Strep-eGFP cassette was inserted before or after the Gateway cassette, to yield GFP-tagged destination vectors. For RPE1 stable cell lines expressing N-terminally tagged PP2A scaffold, the destination vector described above was subcloned to include an FKBP tag before the Strep-tag. These vectors were used in recombination reactions with entry clones containing PP2A regulatory subunits, and the open reading frames were sequence-verified.
Immunological methods. For immunofluorescence microscopy of BubR1, cells on coverslips were fixed in methanol at −20 • C for 10 min. For all other antibodies, cells on coverslips were pre-extracted for 40 s at 37 • C in PEM buffer (100 mM PIPES, 10 mM EGTA and 1 mM MgCl 2 adjusted to pH 6.9 using KOH) with 0.5% Triton X-100 and 4 M glycerol and then fixed for 5 min at 37 • C in form fix (3.7% formaldehyde and 0.2% Triton X-100 in PEM buffer). For analysis of cold-stable microtubules, cells were incubated for 10 min at 4 • C in L-15 media (Invitrogen) with 10% FBS, and then fixed in form fix for 10 min at 22 • C. For the preparation of chromosome spreads, cells were collected by trypsinization, pelleted in media, resuspended in 0.075 M KCl for 20 min at 22 • C and then spun onto poly-d-lysine-coated glass coverslips at 2,000 r.p.m. for 2 min in a Shandon Cytospin 3. All subsequent incubations for immunofluorescence microscopy were carried out at 22 • C. Cells were blocked in 2% donkey serum (Jackson Immunoresearch). The following antibodies were used for immunofluorescence: anti-B56α (BDTransduction Laboratories, #610615, used at 1:250), anti-Plk1 (Santa Cruz # sc-17783 used at 1:200), anti-GFP (raised against full-length GFP and affinity purified and used at 1 µg ml −1 ), anti-phospho Ser 100 Dsn1 and phospho Ser 24 Knl1 (gifts from I. Cheeseman 6 used at 1:1,000), anti-phospho Ser 676 BubR1 (a gift from S. Elowe 34 used at 1:1,000), anti-BubR1 (Millipore #MAB3612, used at 1:500), anti-Dsn1 and anti-Knl1 (gifts from A. Desai 42 used at 1:1,000), anti-Sgo1 antibodies (a gift from H. Yu 14 used at 1:1,000 and Abcam, ab58023, used at 1:200). FITC-conjugated mouse anti-tubulin monoclonal antibody (Sigma # F2168) was used at 1:3,000, and human CREST anti-serum was used at 1:80,000 (a gift from W. Brinkley, Baylor College of Medicine, USA). Secondary antibodies raised in donkey (Jackson Immunoresearch) were used at 2 µg ml −1 and DNA was stained with Hoechst 33342 (Sigma). Coverslips were mounted in 0.5% p-phenylenediamine (Sigma) in 20 mM Tris, at pH 8.8, with 90% glycerol and sealed with nail polish. For western blot analysis, the following antibodies were used: anti-B56α (Bethyl Laboratories, #A300-967A used at 1:3,000), anti-B56β (raised against a peptide corresponding to amino acids 477-497 of human B56β and affinity purified and used at 0.2 µg ml −1 ), anti-B56δ (Santa Cruz, #sc-81605, used at 1:500) or GFP (used at 0.1 µg ml −1 ). HRP-conjugated secondary antibodies raised in donkey were purchased from Jackson Immunoresearch and used at 0.02 µg ml −1 .
Imaging, data acquisition and processing. For live-cell imaging, cells grown on 22 × 22 mm poly-d-lysine-coated coverslips were mounted in a custom Rose chamber in 10% FBS in L-15 media (Invitrogen) without phenol red and maintained at 35-37 • C. Confocal GFP fluorescence micrographs were acquired using a Nikon TE2000 microscope (Morrell Instruments), with a ×100 objective (PlanApo, 1.4 NA), equipped with a z motor. 0.4 µm z stacks were taken through the entire cell with a PerkinElmer Wallac UltraView confocal head, 488 nm excitation filters and an argon ion laser (Solamere). A single DIC image was taken before each z stack. Images were acquired with an EMCCD Photometric Cascade 512B camera (Roper Scientific) with 2 × 2 pixel binning using Metamorph software (MDS Analytical Technologies). ImageJ software (NIH) was used to crop images, adjust contrast and create maximum-intensity projections.
Quantifications of mitotic index, chromosome misalignment and the presence of cold-stable microtubules were scored visually on a Zeiss Axioplan2 microscope (Carl Zeiss MicroImaging), with a ×40 objective (Plan Neo, NA 0.75).
Images of fixed cells were acquired as z stacks with 0.2-0.3 µm spacing using a ×100, 1.35 NA objective on a DeltaVision Image Restoration Microscope (Applied Precision Instruments and Olympus). The immunofluorescence micrographs in Figs 1 and 3 were processed by iterative constrained deconvolution (SoftWoRx, Applied Precision Instruments) and corrected for chromatic aberration. Maximumintensity projections of the entire cell or of selected optical sections (insets) spanning individual centromeres/kinetochores were converted to tiff files and linescans were generated using ImageJ. For immunofluorescence images in Figs 2, 4 and 5, where intensities are compared, the acquired images, without deconvolution, were used to generate a maximum projection of the cell. Images for a given antibody staining were scaled identically, and this scale was then applied when converting it to a tiff file. Images were cropped and adjusted for contrast equivalently in ImageJ. For quantifications of kinetochore pairing, randomly selected chromosome spreads were imaged and individual kinetochores were scored. For quantification of antibody staining intensities at individual kinetochores, five to eight cells or chromosome spreads were randomly selected and acquired on a Deltavision Restoration microscope as described above. Images were scaled identically when converted to tiff files. Quantification of intensities at individual kinetochores was carried out essentially as described in ref. 20 . Briefly, using Metamorph software, integrated staining intensity was quantified from a region of interest drawn manually around a kinetochore. To subtract local background fluorescence, this region of interest was dilated by 6 pixels in Metamorph to generate an 'outer' region. The signal intensity of the 'outer' region was subtracted from the 'inner' kinetochore region, after scaling values for differences in area, as described previously 20 . Finally, the background-subtracted kinetochore-staining intensity was divided by the area of the region of interest. 
